Journal article

Putative neuroprotective agents in neuropsychiatric disorders

Seetal Dodd, Michael Maes, George Anderson, Olivia M Dean, Steven Moylan, Michael Berk

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY | PERGAMON-ELSEVIER SCIENCE LTD | Published : 2013

DOI: 10.1016/j.pnpbp.2012.11.007

Download PDF

Citation metrics

81Web of Science
88Scopus
79Dimensions

Keywords

Clinical Neurology
Life Sciences & Biomedicine
Oxidative Stress Markers
Antipsychotics
Psychiatry
Neuroprotective Agents
Neurosciences
Lithium
Aspirin
a Reductase Inhibitor
Humans
Ultra-High-Risk
Neurosciences & Neurology
Experimental Autoimmune Encephalomyelitis
Statins
Blood-Brain-Barrier
Hematopoietic Growth-Factors
Pharmacology & Pharmacy
Nf-Kappa-B
Melatonin
Bipolar Disorder
Depressive Disorder
Animals
Schizophrenia
Mental Disorders
Nerve Growth Factors
N-Acetyl Cysteine
Open-Label Trial
Neural Stem-Cells
Science & Technology
Lipopolysaccharide-Induced Apoptosis